Leadership and Selection Panel
President
-
Marco Mohwinckel
Magnolia Health Advisors
(United Kingdom)
Tech Tour Advisor
Programme Leaders
-
Antonio Murta
Pathena
(Portugal)
Managing Director
-
Nuno Sousa
University of Minho
(Portugal)
Director of P5 and 2CA Laboratory
Vice President Selection Panel
-
Janke Dittmer
Gilde Healthcare Partners
(Netherlands)
General Partner
Selection Panel
This Selection Panel is responsible for nominating companies, and they will select 30 of the best Mental Health & Brain Tech companies developing highly innovative technologies and solutions that promote mental health, wellness and resilience, as well as biopharmaceuticals, hardware- and software-based solutions that prevent, screen, treat, monitor, rehabilitate, engage, care for and support patients and caregivers suffering with some of the most common debilitating neuro psychiatric and neurological disorders.
Susana Amorim
Investment Manager
Gilde Healthcare Partners
(Netherlands)
Roberto Ascione
President, Health Innovation
EVERSANA
(United States)
Paul Ashley
Director, External Innovation, Data Science and Digital Health
Johnson & Johnson Innovation
(United Kingdom)
Saurin Badiyani
Director, Digital Therapeutics
Pharmanovia
(United Kingdom)
Eric Bennett
Chief Investment Officer & Co-founder
Tolleson Wealth Management
(United States)
Jeanne Bolger
Life Sciences Consultant and Board member
JB BioVentures Consulting Ltd
(Ireland)
Lien Callens
Investment Principal
imec.xpand
(Belgium)
Antoine D'Hollander
Investment Manager
Capricorn Partners
(Belgium)
Stephan de Moraes
Managing General Partner
Indico Capital Partners
(Portugal)
Inga Deakin
Principal, Lifesciences and Digital Health
Molten Ventures
(United Kingdom)
Paolo Di Giorgio
Chief Executive Officer & Managing Director
Angelini Ventures
(Italy)
Robert Garber
Partner
7wireVentures
(United States)
Therapeutics Solutions
Health & Wellness Solutions
Will Gibbs
Healthtech Partner
Octopus Ventures
(United Kingdom)
Health & Wellness Solutions
Screening and Diagnostics Solutions
Vishal Gulati
Managing Partner
Recode Health Ventures
(United States)
Jan Hardorp
re.Mind Capital
(United Kingdom)
Joshua Haynes
Founder & Managing Partner
Masawa
(Germany)
Amy Kruse
General Partner & Chief Investment Officer - Satori Neuro
Satori Capital
(United States)
Antonio Limatola
Senior Associate
Asabys Partners
(Spain)
Ruth McKernan
Venture Partner
SV Health Investors
(United Kingdom)
Therapeutics Solutions
Screening and Diagnostics Solutions
Antonio Murta
Managing Director
Pathena
(Portugal)
Valeri Petrov
Managing Partner
Eleven Ventures
(Bulgaria)
Data and AI Solutions
Health & Wellness Solutions
Medical Devices & Clinical Systems
Giovanni Rizzo
Partner & Key Manager Biotech Fund at Indaco Venture Partners
Indaco Venture Partners
(Italy)
Josep Ll Sanfeliu
Managing Partner
Asabys Partners
(Spain)
Therapeutics Solutions
Data and AI Solutions
Health & Wellness Solutions
Diana Saraceni
General Partner
Panakès Partners
(Italy)
Steve Seuntjens
Partner
PHS Fund
(Netherlands)
Therapeutics Solutions
Health & Wellness Solutions
Screening and Diagnostics Solutions
Marc Sluijs
Managing Partner
DIGITALHEALTH.NETWORK
(Switzerland)
Garth Smith
Ontario Brain Institute
(Canada)
Sarah van Hellenberg Hubar-Fisher
Venture Leader | Board Member | Impact Investor
Growth Science Ventures
(United States)
Ilse Vanhulle
Venture Acceleration Manager
imec
(Belgium)
Therapeutics Solutions
Health & Wellness Solutions
Screening and Diagnostics Solutions
Badri Wadawadigi
Chief Digital Officer
Pharmanovia
(United Kingdom)